| RS1663245097 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1663246215 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1663246649 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1663251692 |
APOB
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1663270865 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1663292441 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1663294340 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1663296303 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1663298665 |
APOB
|
Health Risk |
Likely pathogenic |
Familial hypobetalipoproteinemia 1, Familial hypobetalipoproteinemia 1 |
| RS1663311706 |
COL11A1
|
Health Risk |
Likely pathogenic |
COL11A1-related disorder, COL11A1-related disorder |
| RS1663313424 |
COL11A1
|
Health Risk |
Likely pathogenic |
Marshall syndrome, Marshall syndrome |
| RS1663321162 |
APOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1663338324 |
APOB
|
Health Risk |
Pathogenic |
— |
| RS1663355633 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1663379209 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia |
| RS1663384249 |
DRC1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1663384393 |
APOB
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hypercholesterolemia |
| RS1663391660 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1663402590 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1663429897 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1663450536 |
KCNK3
|
Health Risk |
Pathogenic |
— |
| RS1663516243 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1663520073 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1663522846 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1663550401 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1663553610 |
APOB
|
Health Risk |
Likely pathogenic |
— |
| RS1663556957 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1663578215 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1663584680 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1663631401 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1663633174 |
DDR2
|
Health Risk |
Pathogenic |
— |
| RS1663654908 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1663675984 |
NBAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Short stature-optic atrophy-Pelger-Huët anomaly syndrome, Infantile liver failure syndrome 2 |
| RS1663691728 |
DRC1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1663748771 |
PRKACB
|
Health Risk |
Pathogenic |
Cardioacrofacial dysplasia 2, Cardioacrofacial dysplasia 2 |
| RS1663772190 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1663780024 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1663792524 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1663793007 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiovascular phenotype |
| RS1663812465 |
DRC1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1663813561 |
DBT
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS1663814011 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1663814241 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1663814857 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 2, Maple syrup urine disease type 2 |
| RS1663836291 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1663930286 |
RYR2
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1663951981 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1663959543 |
GALNT2
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type iit |
| RS1663960324 |
GALNT2
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, type iit |
| RS1663984693 |
APOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1664016363 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1664099851 |
FLVCR1
|
Health Risk |
Pathogenic |
— |
| RS1664103646 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1664107730 |
FLVCR1
|
Health Risk |
Likely pathogenic |
— |
| RS1664132167 |
FLVCR1
|
Health Risk |
Pathogenic |
— |
| RS1664140651 |
FLVCR1
|
Health Risk |
Likely pathogenic |
Hereditary sensory and autonomic neuropathy, Retinitis pigmentosa |
| RS1664160163 |
KIDINS220
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1664173086 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1664202070 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1664228420 |
KCND3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1664277152 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Leber congenital amaurosis 8 |
| RS1664289410 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1664290387 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 12 |
| RS1664292210 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1664298414 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 12, Retinal dystrophy |
| RS1664299326 |
ADAM17
|
Health Risk |
Conflicting classifications of pathogenicity |
Inflammatory skin and bowel disease, neonatal |
| RS1664299898 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1664301074 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1664303657 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1664306632 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1664313783 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1664317534 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1664322968 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 8, Intellectual disability |
| RS1664325377 |
CRB1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Autosomal recessive retinitis pigmentosa |
| RS1664329331 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1664341626 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1664343244 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS1664348016 |
CRB1
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Leber congenital amaurosis 8 |
| RS1664428364 |
KIDINS220
|
Health Risk |
Pathogenic |
— |
| RS1664428695 |
KIDINS220
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, intellectual disability |
| RS1664440809 |
OTOF
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS1664490756 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1664499681 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1664521219 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1664579873 |
OTOF
|
Health Risk |
Pathogenic |
— |
| RS1664580718 |
OTOF
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS1664585937 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS1664593626 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marshall syndrome, Marshall syndrome |
| RS1664595275 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1664604921 |
OTOF
|
Health Risk |
Pathogenic |
— |
| RS1664632655 |
KCND3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Spinocerebellar ataxia type 19/22 |
| RS1664642051 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1664643556 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1664649015 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS1664649489 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1664650245 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1664651786 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS1664656299 |
CRB1
|
Health Risk |
Likely pathogenic |
CRB1-related maculopathy, CRB1-related maculopathy |
| RS1664661129 |
MTR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1664661222 |
MTR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblG, Melanoma |